<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Dermally applicable liquid formulations for controlling parasitic insects on animals"><meta name="DC.contributor" content="Kirkor Sirinyan" scheme="inventor"><meta name="DC.contributor" content="Hubert Dorn" scheme="inventor"><meta name="DC.contributor" content="Martin Gilges" scheme="inventor"><meta name="DC.contributor" content="Olaf Hansen" scheme="inventor"><meta name="DC.contributor" content="Bayer Animal Health Gmbh" scheme="assignee"><meta name="DC.date" content="2003-10-9" scheme="dateSubmitted"><meta name="DC.description" content="The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals."><meta name="DC.date" content="2010-6-1" scheme="issued"><meta name="DC.relation" content="AU:633883" scheme="references"><meta name="DC.relation" content="CN:1176052:A" scheme="references"><meta name="DC.relation" content="CN:1234181:A" scheme="references"><meta name="DC.relation" content="CN:1236547:A" scheme="references"><meta name="DC.relation" content="DE:3639877:A1" scheme="references"><meta name="DC.relation" content="DE:3712307:A1" scheme="references"><meta name="DC.relation" content="EP:0135956:A2" scheme="references"><meta name="DC.relation" content="EP:0189972:A1" scheme="references"><meta name="DC.relation" content="EP:0302389:A2" scheme="references"><meta name="DC.relation" content="EP:0364844:A1" scheme="references"><meta name="DC.relation" content="EP:0368565:A1" scheme="references"><meta name="DC.relation" content="EP:0375907:A1" scheme="references"><meta name="DC.relation" content="EP:0383091:A1" scheme="references"><meta name="DC.relation" content="EP:0425978:A2" scheme="references"><meta name="DC.relation" content="EP:0428941:A1" scheme="references"><meta name="DC.relation" content="EP:0455000:A1" scheme="references"><meta name="DC.relation" content="EP:0461962:A1" scheme="references"><meta name="DC.relation" content="EP:0464830:A1" scheme="references"><meta name="DC.relation" content="EP:0471372:A1" scheme="references"><meta name="DC.relation" content="EP:0682869:A1" scheme="references"><meta name="DC.relation" content="EP:0976328:A2" scheme="references"><meta name="DC.relation" content="EP:0981955:A2" scheme="references"><meta name="DC.relation" content="FR:2784011" scheme="references"><meta name="DC.relation" content="JP:H02207083" scheme="references"><meta name="DC.relation" content="JP:H03220176" scheme="references"><meta name="DC.relation" content="JP:H03255072" scheme="references"><meta name="DC.relation" content="JP:H03279359" scheme="references"><meta name="DC.relation" content="JP:H07247203" scheme="references"><meta name="DC.relation" content="JP:H0789803" scheme="references"><meta name="DC.relation" content="JP:H1179917" scheme="references"><meta name="DC.relation" content="JP:S63287764" scheme="references"><meta name="DC.relation" content="JP:S63307857" scheme="references"><meta name="DC.relation" content="RU:2127517" scheme="references"><meta name="DC.relation" content="RU:2130259" scheme="references"><meta name="DC.relation" content="US:20020103233:A1" scheme="references"><meta name="DC.relation" content="US:20030055089:A1" scheme="references"><meta name="DC.relation" content="US:4590272" scheme="references"><meta name="DC.relation" content="US:4647570" scheme="references"><meta name="DC.relation" content="US:4742060" scheme="references"><meta name="DC.relation" content="US:4772620" scheme="references"><meta name="DC.relation" content="US:4774247" scheme="references"><meta name="DC.relation" content="US:4806553" scheme="references"><meta name="DC.relation" content="US:4849432" scheme="references"><meta name="DC.relation" content="US:4882344" scheme="references"><meta name="DC.relation" content="US:4914113" scheme="references"><meta name="DC.relation" content="US:4918086" scheme="references"><meta name="DC.relation" content="US:4918088" scheme="references"><meta name="DC.relation" content="US:4948798" scheme="references"><meta name="DC.relation" content="US:4963572" scheme="references"><meta name="DC.relation" content="US:4963574" scheme="references"><meta name="DC.relation" content="US:4988696" scheme="references"><meta name="DC.relation" content="US:5034404" scheme="references"><meta name="DC.relation" content="US:5034524" scheme="references"><meta name="DC.relation" content="US:5039686" scheme="references"><meta name="DC.relation" content="US:5074252" scheme="references"><meta name="DC.relation" content="US:5236954" scheme="references"><meta name="DC.relation" content="US:5253182" scheme="references"><meta name="DC.relation" content="US:5435992" scheme="references"><meta name="DC.relation" content="US:6001858" scheme="references"><meta name="DC.relation" content="US:6033731" scheme="references"><meta name="DC.relation" content="US:6080796" scheme="references"><meta name="DC.relation" content="US:6232328" scheme="references"><meta name="DC.relation" content="US:7384938" scheme="references"><meta name="DC.relation" content="WO:1991017659:A1" scheme="references"><meta name="DC.relation" content="WO:1995017090:A1" scheme="references"><meta name="DC.relation" content="WO:1996017520:A1" scheme="references"><meta name="DC.relation" content="WO:2000054591:A2" scheme="references"><meta name="DC.relation" content="WO:2002043494:A2" scheme="references"><meta name="citation_reference" content="Calumpang, et al., Applicator Exposure to Imidacloprid while Spraying Mangoes, Bull. Environ. Contam. Toxicol., Nov. 1996, vol. 57, pp. 697-704."><meta name="citation_reference" content="Toda, et al., Toxic Effect of Pesticides on the Larvae of Chrysperla camea, Proc. Assoc. PI. Prot. Kyushu, 1997, vol. 43, pp. 101-105."><meta name="citation_reference" content="Wamhoff, et al., Photodegradation of Imidacloprid, Journal of Agricultural and Food Chemistry, Apr. 1999, vol. 47, No. 4, pp. 1730-1734."><meta name="citation_reference" content="Zheng et al., Kinetics and Mechanism of the hydrolysis of Imidacloprid, Pesticide Science, Apr. 1999, vol. 55, No. 4, pp. 482-485."><meta name="citation_patent_number" content="US:7728011"><meta name="citation_patent_application_number" content="US:10/682,127"><link rel="canonical" href="http://www.google.com/patents/US7728011"/><meta property="og:url" content="http://www.google.com/patents/US7728011"/><meta name="title" content="Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on animals"/><meta name="description" content="The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals."/><meta property="og:title" content="Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on animals"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("JUnsU5HZF5euggSM2oGYAQ"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("BRA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("JUnsU5HZF5euggSM2oGYAQ"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("BRA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us7728011?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US7728011"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS7728011&amp;usg=AFQjCNHNvfAfu9b9itjNWOjzLKqbDZ82_w" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US7728011.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US7728011.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20040161441"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20090017084"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US7728011"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US7728011" style="display:none"><span itemprop="description">The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals....</span><span itemprop="url">http://www.google.com/patents/US7728011?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on animals</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on animals" title="Patent US7728011 - Dermally applicable liquid formulations for controlling parasitic insects on animals"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US7728011 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 10/682,127</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Jun 1, 2010</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Oct 9, 2003</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Apr 9, 2001</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2443159A1">CA2443159A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2443159C">CA2443159C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN1501773A">CN1501773A</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN100337545C">CN100337545C</a>, </span><span class="patent-bibdata-value"><a href="/patents/CN101036648A">CN101036648A</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE10117676A1">DE10117676A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE50204946D1">DE50204946D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1379138A1">EP1379138A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1379138B1">EP1379138B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20040161441">US20040161441</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20090017084">US20090017084</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2002087338A1">WO2002087338A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">10682127, </span><span class="patent-bibdata-value">682127, </span><span class="patent-bibdata-value">US 7728011 B2, </span><span class="patent-bibdata-value">US 7728011B2, </span><span class="patent-bibdata-value">US-B2-7728011, </span><span class="patent-bibdata-value">US7728011 B2, </span><span class="patent-bibdata-value">US7728011B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Kirkor+Sirinyan%22">Kirkor Sirinyan</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Hubert+Dorn%22">Hubert Dorn</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Martin+Gilges%22">Martin Gilges</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Olaf+Hansen%22">Olaf Hansen</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bayer+Animal+Health+Gmbh%22">Bayer Animal Health Gmbh</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US7728011.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7728011.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7728011.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (68),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (4),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (2),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (28),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (6)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/7728011&usg=AFQjCNFd6FpZoekzwz_q98w7I82pWNNnLg">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D7728011&usg=AFQjCNHBIL3EvUfegY7B7eGbpTxhI0c81A">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D7728011B2%26KC%3DB2%26FT%3DD&usg=AFQjCNHSbwf08_PwVimTaG4SQyPM_USYFg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT95765715" lang="EN" load-source="patent-office">Dermally applicable liquid formulations for controlling parasitic insects on animals</invention-title></span><br><span class="patent-number">US 7728011 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA78596239" lang="EN" load-source="patent-office"> <div num="p-0001" class="abstract">The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(11)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US7728011-10.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US7728011-10.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(4)</span></span></div><div class="patent-text"><div mxw-id="PCLM31975090" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text">1. A composition for controlling parasites on an animal comprising:
<div class="claim-text">a. from about 35% to about 60% by weight of permethrin;</div>
<div class="claim-text">b. from about 2.5% to about 12.5% by weight of imidacloprid or an imidacloprid analog;</div>
<div class="claim-text">c. from about 27.5% to about 62.5% by weight of N-methylpyrrolidone;</div>
<div class="claim-text">d. from 0% to about 5% by weight of water;</div>
<div class="claim-text">e. from 0% to about 0.5% by weight of phenolic antioxidants; and</div>
<div class="claim-text">f. from 0% to about 0.5% by weight of at least one organic acid.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text">2. The composition of <claim-ref idref="CLM-00001">claim 1</claim-ref>, further comprising from about 2.5% to about 10% by weight of at least one cosolvent.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text">3. The composition of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein said parasite is selected from the group consisting of fleas, ticks and both fleas and ticks and wherein said animal is warm-blooded.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text">4. The composition of <claim-ref idref="CLM-00003">claim 3</claim-ref>, wherein said animal is a dog.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES37344329" lang="EN" load-source="patent-office" class="description">
    <p num="p-0002">The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.</p>
    <p num="p-0003">The use of topical formulations comprising permethrin, i.e. (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylates [CAS No. 52645-53-1], for controlling parasitic insects on animals is known (cf., for example, WO 95/17 090, JP-07 247 203, EP-A-567 368, EP-A461 962, U.S. Pat. Nos. 5,236,954 and 5,074,252).</p>
    <p num="p-0004">Agonists or antagonists of the nicotinic acetylcholine receptors of insects are known, for example are known from agonists or antagonists of the nicotinic acetylcholine receptors of insects, for example from the European Laid-Open Applications Nos. 464 830, 428 941, 425 978, 386 565, 383 091, 375 907, 364 844, 315 826, 259 738, 254 859, 235 725, 212 600, 192 060, 163 855, 154 178, 136 636, 303 570, 302 833, 306 696, 189 972, 455 000, 135 956, 471 372, 302 389; the German Laid-Open Applications Nos. 3 639 877, 3 712 307; the Japanese Laid-Open Publications Nos. 03 220 176, 02 207 083, 63 307 857, 63 287 764, 03 246 283, 04 9371, 03 279 359, 03 255 072; U.S. Pat. Nos. 5,034,524, 4,948,798, 4,918,086, 5,039,686, 5,034,404; PCT Applications Nos. WO 91/17 659, 92/4965; the French Application No. 2611 114; the Brazilian Application No. 88 03 621. Also known is the use of spot-on formulations comprising agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals (see, for example, WO 98/27 817, EP-A-682 869 and EP 0 976 328).</p>
    <p num="p-0005">Combinations of permethrin with agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasites have likewise already been described in the prior art (cf., for example, CN-1 245 637, WO 00/54 591, U.S. Pat. No. 6,080,796, EP-A-981 955, U.S. Pat. No. 6,033,731, JP-07 089 803).</p>
    <p num="p-0006">The disadvantage of the permethrin-based spot-on formulations is the low activity against ticks and fleas.</p>
    <p num="p-0007">In general, spot-on formulations based on agonists or antagonists of nicotinic acetylcholine receptors are highly active against fleas. However, they have the disadvantage that they are ineffective against ticks.</p>
    <p num="p-0008">Unfortunately, the known combination formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors are not particularly suitable for controlling parasites on animals, in particular pets. They require the use of relatively large amounts of active compound and, in many cases, cause skin irritations. Permethrin is a strongly aprotic compound, whereas agonists and antagonists of nicotinic acetylcholine receptors, in particular imidacloprid analogues, are protic compounds. Accordingly, it is not easy to find a dermally applicable liquid formulation which comprises both active compounds and has the following properties:
</p> <ul> <li id="ul0001-0001" num="0000"> <ul> <li id="ul0002-0001" num="0008">good solubility of the active compounds</li> <li id="ul0002-0002" num="0009">skin-friendly</li> <li id="ul0002-0003" num="0010">low toxicity</li> <li id="ul0002-0004" num="0011">low skin penetration (since the action of the active compounds should preferably be non-systemic)</li> <li id="ul0002-0005" num="0012">high efficacy.</li> </ul> </li> </ul> <p num="p-0009">For this reason, successful control of ticks and fleas hitherto required a treatment of the animals with both of the said spot-on formulations. For ecological and economic reasons, it is desirable to replace these formulations by formulations which are skin-friendly and toxicologically acceptable and which are furthermore distinguished by good long-term action of at least three to four weeks, especially against ticks and fleas, at a small applicable volume (for example 0.1 ml/1.0 kg [body weight of the animal to be treated]). Furthermore, such a formulation should, in all climate zones, be sufficiently storage-stable, usually for at least three years, for example in the conventional spot-on tubes.</p>
    <p num="p-0010">Accordingly, it was an object of the present invention to provide an easy-to-use skin-friendly and environmentally friendly formulation for dermal application active against parasitic insects, in particular against ticks and fleas, which formulation comprises permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects.</p>
    <p num="p-0011">This object is achieved by the compositions according to the invention described below.</p>
    <p num="p-0012">The present invention relates to</p>
    <p num="p-0013">1. compositions, comprising
</p> <ul> <li id="ul0003-0001" num="0018">a) 35-60% by weight of the active compound permethrin</li> <li id="ul0003-0002" num="0019">b) 2.5-12.5% by weight of imidacloprid or an imidacloprid analogue</li> <li id="ul0003-0003" num="0020">c) 27.5-62.5% by weight of N-methylpyrrolidone</li> <li id="ul0003-0004" num="0021">d) 0-5% by weight of water</li> <li id="ul0003-0005" num="0022">e) 0-0.5% by weight of phenolic antioxidants and</li> <li id="ul0003-0006" num="0023">f) 0-0.5% by weight of organic acids.</li> </ul> <p num="p-0014">The stated percentages by weight are based on the total weight.</p>
    <p num="p-0015">According to a preferred embodiment, the compositions according to the invention additionally comprise
</p> <ul> <li id="ul0004-0001" num="0026">g) 2.5-10% by weight of cosolvent.</li> </ul> <p num="p-0016">The compositions according to the invention are usually liquid and are suitable for dermal application, in particular as pour-on or spot-on formulations.</p>
    <p num="p-0017">Surprisingly, the ectoparasiticidal activity of the compositions according to the invention comprising permethrin in combination with imidacloprid or an imidacloprid analogue is higher than would have been expected from the activities of the individual components. By using these compositions, it is therefore possible to reduce the application rates of active compound and to increase long-term action. As a result, their use has economic and ecological advantages.</p>
    <p num="p-0018">The compositions according to the invention are highly suitable for use in controlling parasites.</p>
    <p num="p-0019">Parasites which may be mentioned are:
</p> <ul> <li id="ul0005-0001" num="0031">from the order of the Anoplura e.g. <i>Haematopinus </i>spp., <i>Linognathus </i>spp., <i>Solenopotes </i>spp., <i>Pediculus </i>spp., <i>Pthirus </i>spp.;</li> <li id="ul0005-0002" num="0032">from the order of the Mallophaga e.g. <i>Trimenopon </i>spp., <i>Menopon </i>spp., <i>Eomenacanthus </i>spp., <i>Menacanthus </i>spp., <i>Trichodectes </i>spp., <i>Felicola </i>spp., <i>Damalinea </i>spp., <i>Bovicola </i>spp.;</li> <li id="ul0005-0003" num="0033">from the order of the Diptera e.g. <i>Aedes </i>spp., <i>Culex </i>spp., <i>Simulium </i>spp., <i>Phlebotomus </i>spp., <i>Chrysops </i>spp., <i>Tabanus </i>spp., <i>Musca </i>spp., <i>Hydrotaea </i>spp., <i>Muscina </i>spp., <i>Haematobosca </i>spp., <i>Haematobia </i>spp., <i>Stomoxys </i>spp., <i>Fannia </i>spp., <i>Glossina </i>spp., <i>Lucilia </i>spp., <i>Calliphora </i>spp., <i>Auchmero</i>-<i>myia </i>spp., <i>Cordylobia </i>spp., <i>Cochliomyia </i>spp., <i>Chrysomyia </i>spp., <i>Sarcophaga </i>spp., <i>Wohlfartia </i>spp., <i>Gasterophilus </i>spp., <i>Oesteromyia </i>spp., <i>Oedemagena </i>spp., <i>Hypoderma </i>spp., <i>Oestrus </i>spp., <i>Rhinoestrus </i>spp., <i>Melophagus </i>spp., <i>Hippobosca </i>spp.;</li> <li id="ul0005-0004" num="0034">from the order of the Siphonaptera e.g. <i>Ctenocephalides </i>spp., <i>Echidnophaga </i>spp., <i>Ceratophyllus </i>spp., <i>Pulex </i>spp.;</li> <li id="ul0005-0005" num="0035">from the order of the Metastigmata e.g. <i>Hyalomma </i>spp., <i>Rhipicephalus </i>spp., <i>Boophilus </i>spp., <i>Amblyomma </i>spp., <i>Haemaphysalis </i>spp., <i>Dermacentor </i>spp., <i>Ixodes </i>spp., <i>Argas </i>spp., <i>Ornithodorus </i>spp., <i>Otobius </i>spp.;</li> <li id="ul0005-0006" num="0036">from the order of the Mesostigmata e.g. <i>Dermanyssus </i>spp., <i>Ornithonyssus </i>spp., <i>Pneumonyssus </i>spp.;</li> <li id="ul0005-0007" num="0037">from the order of the Prostigmata e.g. <i>Cheyletiella </i>spp., <i>Psorergates </i>spp., <i>Myobia </i>spp., <i>Demodex </i>spp., <i>Neotrombi-cula </i>spp.;</li> <li id="ul0005-0008" num="0038">from the order of the Astigmata e.g. <i>Acarus </i>spp., <i>Myocoptes </i>spp., <i>Psoroptes </i>spp., <i>Chorioptes </i>spp., <i>Otodectes </i>spp., <i>Sarcoptes </i>spp., <i>Notoedres </i>spp., <i>Knemidocoptes </i>spp., <i>Neoknemidocoptes </i>spp. <i>Cytodites </i>spp., <i>Laminosioptes </i>spp.</li> </ul> <p num="p-0020">The compositions according to the invention are particularly suitable for controlling ectoparasites, preferably ticks and/or fleas, on animals, in particular warm-blooded animals. The compositions according to the invention are preferably used for pets. Here, pets are to be understood as including, in particular, dogs, cats and other warm-blooded animals of a size not greater than that of a dog; i.e. they have a body weight of generally not more than 90 kg, preferably not more than 50 kg. The compositions according to the invention are particularly preferably used for dogs and cats, in particular for dogs.</p>
    <p num="p-0021">Since the treated animals generally also spread a certain amount of the composition used in the surroundings, for example by scratching or debris, the compositions according to the invention may act not only directly on the animal but, correspondingly, also in their surroundings.</p>
    <p num="p-0022">To prepare the liquid formulations according to the invention, it is possible to use all customary isomer mixtures of the active permethrin compound. The preferred isomer mixture comprises 35-45% of cis- and 55-65% of trans-permethrin. The particularly preferred isomer mixture comprises 37.5-42.5% of cis- and 57.5-62.5% of trans-permethrin.</p>
    <p num="p-0023">The amounts of permethrin in the composition according to the invention can be varied broadly between 35 and 60%. Preference is given to amounts in the range of 45-60%, and, with particular preference, the composition according to the invention comprises permethrin in the range of 47.5-55%.</p>
    <p num="p-0024">Likewise, it is possible to vary the amounts of imidacloprid or imidacloprid analogue broadly between 2.5 and 12.5%, where preference is given to amounts in the range of 5.0-10.0%. With particular preference, imidacloprid or the imidacloprid analogue is used in the compositions according to the invention in amounts in the range of 7.5-10%.</p>
    <p num="p-0025">Of course, said formulations may also comprise further suitable active compounds.</p>
    <p num="p-0026">Examples which may be mentioned are growth-inhibiting active compounds and synergists, pyriproxyfen {2-[1-methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine CAS No.: 95737-68-1}, methopren [(E,E)-1-methylethyl 11-methoxy-3,7,11-trimethyl-2, 4-dodecadieneoate, CAS No.: 40596-69-8] and triflumuron {2-chloro-N-[[[4-(tri-fluoromethoxy)phenyl]amino]carbonyl]benzamide CAS No.: 64628-44-0}.</p>
    <p num="p-0027">Agonists or antagonists of the nicotinic acetylcholine receptors of insects which may be mentioned as being preferred are imidacloprid analogues.</p>
    <p num="p-0028">Imidacloprid analogues are to be understood as meaning compounds of the formula (I):</p>
    <p num="p-0029"> <chemistry id="CHEM-US-00001" num="00001"> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00001.png"> <img id="EMI-C00001" he="17.70mm" wi="49.19mm" file="US07728011-20100601-C00001.TIF" alt="Figure US07728011-20100601-C00001" img-content="chem" img-format="tif" src="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00001.png" class="patent-full-image" width="196" height="70"> </a> </div> <attachments> <attachment idref="CHEM-US-00001" attachment-type="cdx" file="US07728011-20100601-C00001.CDX"> </attachment> <attachment idref="CHEM-US-00001" attachment-type="mol" file="US07728011-20100601-C00001.MOL"> </attachment> </attachments> </chemistry> <br>
in which
</p> <ul> <li id="ul0006-0001" num="0049">R represents hydrogen or optionally substituted radicals from the group consisting of acyl, alkyl, aryl, aralkyl, heteroaryl and heteroarylalkyl;</li> <li id="ul0006-0002" num="0050">A represents a monofunctional group from the group consisting of hydrogen, acyl, alkyl, aryl or represents a bifunctional group which is attached to the radical Z;</li> <li id="ul0006-0003" num="0051">E represents an electron-withdrawing radical;</li> <li id="ul0006-0004" num="0052">X represents the radicals —CH═ or ═N—, where the radical —CH═ may be attached to the radical Z instead of a hydrogen atom;</li> <li id="ul0006-0005" num="0053">Z represents a monofunctional group from the group consisting of alkyl, —O—R, —S—R,</li> </ul> <p num="p-0030">
      <chemistry id="CHEM-US-00002" num="00002"> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00002.png"> <img id="EMI-C00002" he="12.19mm" wi="9.99mm" file="US07728011-20100601-C00002.TIF" alt="Figure US07728011-20100601-C00002" img-content="chem" img-format="tif" src="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00002.png" class="patent-full-image" width="39" height="48"> </a> </div>
        <attachments> <attachment idref="CHEM-US-00002" attachment-type="cdx" file="US07728011-20100601-C00002.CDX"> </attachment> <attachment idref="CHEM-US-00002" attachment-type="mol" file="US07728011-20100601-C00002.MOL"> </attachment> </attachments> </chemistry> </p> <ul> <li id="ul0007-0001" num="0055"> or represents a bifunctional group which is attached to the radical A or the radical X.</li>
      </ul> <p num="p-0031">Particular preference is given to compounds of the formula (I) in which the radicals are as defined below:
</p> <ul> <li id="ul0008-0001" num="0057">R represents hydrogen and also represents optionally substituted radicals from the group consisting of acyl, alkyl, aryl, aralkyl, heteroaryl, heteroarylalkyl.
    <ul> <li id="ul0009-0001" num="0058">Acyl radicals which may be mentioned are formyl, alkylcarbonyl, arylcarbonyl, alkylsulphonyl, arylsulphonyl, (alkyl)(aryl)phosphoryl, which for their part may be substituted.</li> <li id="ul0009-0002" num="0059">Alkyl which may be mentioned is C<sub>1-10</sub>-alkyl, in particular C<sub>1-4</sub>-alkyl, specifically methyl, ethyl, isopropyl, sec- or tert-butyl, which for their part may be substituted.</li> <li id="ul0009-0003" num="0060">Aryl which may be mentioned are phenyl and naphthyl, in particular phenyl.</li> <li id="ul0009-0004" num="0061">Aralkyl which may be mentioned are phenylmethyl and phenethyl.</li> <li id="ul0009-0005" num="0062">Heteroaryl which may be mentioned is heteroaryl having up to 10 ring atoms and, as heteroatoms, N, O and S, in particular N. Specific mention may be made of thienyl, furyl, thiazolyl, imidazolyl, pyridyl, benzothiazolyl.</li> <li id="ul0009-0006" num="0063">Heteroarylalkyl which may be mentioned are heteroarylmethyl and heteroarylethyl having up to 6 ring atoms and, as heteroatoms, N, O, S, in particular N.</li> <li id="ul0009-0007" num="0064">Exemplary and preferred substituents are:</li> <li id="ul0009-0008" num="0065">alkyl having preferably 1 to 4, in particular 1 or 2, carbon atoms, such as methyl, ethyl, n- and isopropyl and n-, iso- and tert-butyl; alkoxy having preferably 1 to 4, in particular 1 or 2, carbon atoms, such as methoxy, ethoxy, n- and isopropyloxy and n-, iso- and tert-butyloxy; alkylthio having preferably 1 to 4, in particular 1 or 2, carbon atoms, such as methylthio, ethylthio, n- and isopropylthio and n-, iso- and tert-butylthio; haloalkyl having preferably 1 to 4, in particular 1 or 2, carbon atoms and preferably 1 to 5, in particular 1 to 3, halogen atoms, where the halogen atoms are identical or different and are preferably fluorine, chlorine or bromine, in particular fluorine, such as trifluoromethyl; hydroxyl; halogen, preferably fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine; cyano; nitro; amino; monoalkyl- and dialkylamino having preferably 1 to 4, in particular 1 or 2, carbon atoms per alkyl group, such as methylamino, methylethylamino, n- and isopropylamino and methyl-n-butylamino; carboxyl; carbalkoxy having preferably 2 to 4, in particular 2 or 3, carbon atoms, such as carbomethoxy and carboethoxy; sulpho (—SO<sub>3</sub>H); alkylsulphonyl having preferably 1 to 4, in particular 1 or 2, carbon atoms, such as methylsulphonyl and ethylsulphonyl; arylsulphonyl having preferably 6 or 10 aryl carbon atoms, such as phenylsulphonyl, and also heteroarylamino and heteroarylalkylamino, such as chloropyridylamino and chloropyridylmethylamino.</li> </ul> </li> <li id="ul0008-0002" num="0066">A particularly preferably represents hydrogen and also represents optionally substituted radicals from the group consisting of acyl, alkyl, aryl, which are preferably as defined under R. A furthermore represents a bifunctional group. Mention may be made of optionally substituted alkylene having 1-4, in particular 1-2, carbon atoms, substituents which may be mentioned being the substituents listed further above, where the alkylene groups may be interrupted by heteroatoms from the group consisting of N, O and S.</li> <li id="ul0008-0003" num="0067">A and Z together with the atoms to which they are attached may form a saturated or unsaturated heterocyclic ring. The heterocyclic ring may contain a further 1 or 2 identical or different heteroatoms and/or hetero groups. Preferred heteroatoms are oxygen, sulphur or nitrogen and preferred hetero groups are N-alkyl, where the alkyl of the N-alkyl group contains preferably 1 to 4, in particular 1 or 2, carbon atoms. Alkyl which may be mentioned are methyl, ethyl, n- and isopropyl and n-, iso- and tert-butyl. The heterocyclic ring contains 5 to 7, preferably 5 or 6, ring members.
    <ul> <li id="ul0010-0001" num="0068">Examples of the heterocyclic ring which may be mentioned are pyrrolidine, piperidine, piperazine, hexamethyleneimine, hexahydro-1,3,5-triazine, morpholine, which may optionally be substituted, preferably by methyl.</li> </ul> </li> <li id="ul0008-0004" num="0069">E represents an electron-withdrawing radical, where mention may be made in particular of NO<sub>2</sub>, CN, haloalkylcarbonyl, such as 1,5-halo-C<sub>1-4</sub>-carbonyl, in particular COCF<sub>3</sub>.</li> <li id="ul0008-0005" num="0070">X represents —CH═ or —N═.</li> <li id="ul0008-0006" num="0071">Z represents optionally substituted radicals alkyl, —OR, —SR, —NRR, where R and the substituents preferably have the meaning given above.</li> <li id="ul0008-0007" num="0072">Z can furthermore, in addition to the ring mentioned above, form, together with the atom to which it is attached and the radical</li> </ul> <p num="p-0032">
      <chemistry id="CHEM-US-00003" num="00003"> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00003.png"> <img id="EMI-C00003" he="6.69mm" wi="11.35mm" file="US07728011-20100601-C00003.TIF" alt="Figure US07728011-20100601-C00003" img-content="chem" img-format="tif" src="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00003.png" class="patent-full-image" width="45" height="26"> </a> </div>
        <attachments> <attachment idref="CHEM-US-00003" attachment-type="cdx" file="US07728011-20100601-C00003.CDX"> </attachment> <attachment idref="CHEM-US-00003" attachment-type="mol" file="US07728011-20100601-C00003.MOL"> </attachment> </attachments> </chemistry> </p> <ul> <li id="ul0011-0001" num="0074"> instead of X, a saturated or unsaturated heterocyclic ring. The heterocyclic ring may contain a further 1 or 2 identical or different heteroatoms and/or hetero groups. Preferred heteroatoms are oxygen, sulphur or nitrogen and preferred hetero groups are N-alkyl, where the alkyl or N-alkyl group contains preferably 1 to 4, in particular 1 or 2, carbon atoms. Alkyl which may be mentioned are methyl, ethyl, n- and isopropyl and n-, iso- and tert-butyl. The heterocyclic ring contains 5 to 7, preferably 5 or 6, ring members.
    <ul> <li id="ul0012-0001" num="0075">Examples of the heterocyclic ring which may be mentioned are pyrrolidine, piperidine, piperazine, hexamethyleneimine, morpholine and N-methyl-piperazine.</li> </ul> </li>
      </ul> <p num="p-0033">Compounds which can be used according to the invention with very particular preference are compounds of the general formulae (II) and (III):</p>
    <p num="p-0034"> <chemistry id="CHEM-US-00004" num="00004"> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00004.png"> <img id="EMI-C00004" he="70.53mm" wi="64.18mm" file="US07728011-20100601-C00004.TIF" alt="Figure US07728011-20100601-C00004" img-content="chem" img-format="tif" src="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00004.png" class="patent-full-image" width="256" height="282"> </a> </div> <attachments> <attachment idref="CHEM-US-00004" attachment-type="cdx" file="US07728011-20100601-C00004.CDX"> </attachment> <attachment idref="CHEM-US-00004" attachment-type="mol" file="US07728011-20100601-C00004.MOL"> </attachment> </attachments> </chemistry> <br>
in which
</p> <ul> <li id="ul0013-0001" num="0078">n represents 1 or 2,</li> <li id="ul0013-0002" num="0079">Subst. represents one of the substitutents listed above, in particular halogen, very preferably chlorine,</li> <li id="ul0013-0003" num="0080">A, Z, X and E are as defined above.</li> </ul> <p num="p-0035">The following particularly preferred compounds (imidacloprid and analogues) may be specifically mentioned:</p>
    <p num="p-0036">
      <chemistry id="CHEM-US-00005" num="00005"> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00005.png"> <img id="EMI-C00005" he="239.18mm" wi="69.60mm" file="US07728011-20100601-C00005.TIF" alt="Figure US07728011-20100601-C00005" img-content="chem" img-format="tif" src="//patentimages.storage.googleapis.com/US7728011B2/US07728011-20100601-C00005.png" class="patent-full-image" width="278" height="956"> </a> </div>
        <attachments> <attachment idref="CHEM-US-00005" attachment-type="cdx" file="US07728011-20100601-C00005.CDX"> </attachment> <attachment idref="CHEM-US-00005" attachment-type="mol" file="US07728011-20100601-C00005.MOL"> </attachment> </attachments> </chemistry> </p>
    <p num="p-0037">The amount of N-methylpyrrolidone may be varied in the range of 27.5 to 62.5% by weight. Preferably it is from 35 to 50% by weight, particularly preferably from 40 to 45% by weight.</p>
    <p num="p-0038">The amounts of antioxidant may be varied broadly in the range of 0-0.5%, where preference is given to amounts in the range of 0.05-0.25%. With particular preference, amounts in the range of 0.05-0.15% are used for preparing the compositions according to the invention. All customary antioxidants are suitable, preferably phenolic antioxidants, such as, for example, butylated hydroxytoluene, butylated hydroxyanisole, tocopherol.</p>
    <p num="p-0039">The amount of organic acid may be varied broadly in the range of 0-0.5%, where preference is given to amounts in the range of 0.05-0.25%. With particular preference, amounts in the range of 0.05-0.15% are used for preparing the compositions according to the invention. Suitable for use in the compositions according to the invention are all pharmaceutically acceptable organic acids, in particular carboxylic acids, such as, for example, citric acid, tartaric acid, lactic acid, succinic acid and malic acid. Particular preference is given to the organic acids citric acid and malic acid. Very particular preference is given to citric acid. Their amount can be varied broadly, in particular in the range of 0.05 to 0.25%, where particular preference is again given to amounts in the range of 0.075-0.15%.</p>
    <p num="p-0040">The amounts of cosolvent may be varied broadly in the range of 2.5-10% by weight, where preference is given to amounts in the range of 2.5-7.5% by weight. With particular preference, amounts in the range of 3.5-6.0% by weight are used in the compositions according to the invention.</p>
    <p num="p-0041">Suitable cosolvents are organic solvents having a boiling point &gt;80° C. and a flash point &gt;75° C. The cosolvents preferably have a spreading action. In this context, reference may be made to relatively high-boiling aliphatic and also aromatic alcohols, aliphatic polyethers, aliphatic and/or aromatic esters and cyclic and/or acyclic carbonates.</p>
    <p num="p-0042">However, for preparing the compositions according to the invention, preference is given to using aliphatic acyclic or cyclic ethers or polyethers and also fatty acid esters, in particular triglycerides.</p>
    <p num="p-0043">Suitable for use in the compositions according to the invention are ethers or polyethers, for example from the group consisting of diethylene glycol monoethyl ether, dipropylene glycol monomethyl ether, tetrahydrofurfuryl alcohol and tetrahydrofurfuryl ethoxylate, where the two last-mentioned compounds are particularly preferred.</p>
    <p num="p-0044">Fatty acid esters and triglycerides which may be mentioned are, for example:
</p> <ul> <li id="ul0014-0001" num="0000"> <ul> <li id="ul0015-0001" num="0091">isopropyl myristate, Miglyol 810, Miglyol 812, Miglyol 818, Miglyol 829, Miglyol 840 and Miglyol 8810 (for the definition of the miglyols see, for example, H. P. Fiedler, Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete [Encyclopaedia of Auxiliaries for Pharmacy, Cosmetics and Related Fields], pages 1008-1009, Vol. 2, Publisher Cantor Verlag Aulendorf (1996)).</li> </ul> </li> </ul> <p num="p-0045">From the experiments carried out so far, it can be seen that the mixtures according to the invention modified with the cosolvents mentioned are distinguished by their better skin- and eye-friendliness, better biological activity and by their more favourable stability properties under cold conditions in the customary single-dose application tubes.</p>
    <p num="p-0046">In addition to the components listed above, the compositions according to the invention may comprise further pharmaceutically acceptable auxiliaries. Auxiliaries which may be mentioned are, for example: spreaders and surfactants.</p>
    <p num="p-0047">Spreaders are, for example, spreading oils, such as di-2-ethylhexyl adipate, isopropyl myristate, dipropylene glycol pelargonate, cyclic and acyclic silicone oils, such as dimethicone, and further co- and terpolymers thereof with ethylene oxide, propylene oxide and formaldehyde, fatty acid esters, triglycerides, fatty alcohols.</p>
    <p num="p-0048">Surfactants which may be mentioned are: nonionic surfactants, for example polyethoxylated castor oil, polyethoxylated sorbitan monooleate, sorbitan monostearate, glycerol monostearate, polyoxyethyl stearate, alkylphenol polyglycol ethers;
</p> <ul> <li id="ul0016-0001" num="0096">ampholytic surfactants, such as di-Na N-lauryl-β-iminodipropionate or lecithin;</li> <li id="ul0016-0002" num="0097">anionic surfactants, such as Na lauryl sulphate, fatty alcohol ether sulphates, mono/dialkyl polyglycol ether orthophosphoric acid ester monoethanolamnine salt;</li> <li id="ul0016-0003" num="0098">cationic surfactants, such as cetyltrimethylammonium chloride.</li> </ul> <p num="p-0049">The compositions according to the invention can be prepared by customary processes, for example by mixing the active compounds with stirring with the other components and preparing a solution. The solution may, if appropriate, be filtered. Suitable containers are, for example, plastic tubes.</p>
    <p num="p-0050">The liquid formulations according to the invention are distinguished by their excellent storage stability of at least three years in all climate zones. Owing to the high efficacy, the application volume may be kept small. Preferred application volumes are 0.075-0.25 ml/1.0 kg [body weight of the pet to be treated], preferably 0.1-0.15 ml/1.0 kg [body weight of the pet to be treated].</p>
    <p num="p-0051">The formulations are highly suitable for being filled into and sold in storage-critical containers, such as, for example, single dose polypropylene tubes having a wall thickness of 300-500 μm and a filling volume of 1.0-4.0 ml.</p>
    <p num="p-0052">Moreover, the compositions according to the invention are highly skin-friendly and have low toxicity.</p>
    <p num="p-0053">Finally, owing to their biological degradability, they are environmentally friendly.</p>
    <heading>EXAMPLES</heading> <heading>Example 1</heading> <p num="p-0054">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0017-0001" num="0105">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0017-0002" num="0106">10 g imidacloprid (1-[(6-chloro-3-pyridine)methyl]-N-nitro-2-imidazolidinium) from Bayer AG</li> <li id="ul0017-0003" num="0107">44.8 g N-methylpyrrolidone
    <ul> <li id="ul0018-0001" num="0108">0.1 g citric acid</li> <li id="ul0018-0002" num="0109">0.1 g BHT (butylated hydroxytoluene)</li> </ul> </li> </ul> <heading>Example 2</heading> <p num="p-0055">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0019-0001" num="0111">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0019-0002" num="0112">10 g imidacloprid</li> <li id="ul0019-0003" num="0113">40.8 g N-methylpyrrolidone
    <ul> <li id="ul0020-0001" num="0114">4.0 g water</li> <li id="ul0020-0002" num="0115">0.1 g citric acid</li> <li id="ul0020-0003" num="0116">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 3</heading> <p num="p-0056">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0021-0001" num="0118">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0021-0002" num="0119">10 g Ti 435, Chlothianidine from Takeda AG</li> <li id="ul0021-0003" num="0120">44.8 g N-methylpyrrolidone
    <ul> <li id="ul0022-0001" num="0121">0.1 g citric acid</li> <li id="ul0022-0002" num="0122">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 4</heading> <p num="p-0057">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0023-0001" num="0124">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0023-0002" num="0125">10 g Diacloden (thiamethoxam) from Novartis AG</li> <li id="ul0023-0003" num="0126">44.8 g N-methylpyrrolidone
    <ul> <li id="ul0024-0001" num="0127">0.1 g citric acid</li> <li id="ul0024-0002" num="0128">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 5</heading> <p num="p-0058">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0025-0001" num="0130">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0026-0001" num="0131">7.5 g imidacloprid</li> </ul> </li> <li id="ul0025-0002" num="0132">43.3 g N-methylpyrrolidone
    <ul> <li id="ul0027-0001" num="0133">4.0 g water</li> <li id="ul0027-0002" num="0134">0.1 g citric acid</li> <li id="ul0027-0003" num="0135">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 6</heading> <p num="p-0059">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0028-0001" num="0137">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0028-0002" num="0138">10.0 g imidacloprid</li> <li id="ul0028-0003" num="0139">38.3 g N-methylpyrrolidone
    <ul> <li id="ul0029-0001" num="0140">4.0 g water</li> <li id="ul0029-0002" num="0141">0.1 g citric acid</li> <li id="ul0029-0003" num="0142">0.1 g BHT (butylated hydroxytoluene)</li> </ul> </li> </ul> <heading>Example 7</heading> <p num="p-0060">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0030-0001" num="0144">47.5 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0030-0002" num="0145">10 g imidacloprid</li> <li id="ul0030-0003" num="0146">42.3 g N-methylpyrrolidone
    <ul> <li id="ul0031-0001" num="0147">0.1 g citric acid</li> <li id="ul0031-0002" num="0148">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 8</heading> <p num="p-0061">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0032-0001" num="0150">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0033-0001" num="0151">8 g imidacloprid</li> </ul> </li> <li id="ul0032-0002" num="0152">46.8 g N-methylpyrrolidone
    <ul> <li id="ul0034-0001" num="0153">0.1 g lactic acid</li> <li id="ul0034-0002" num="0154">0.1 g BHT</li> </ul> </li> </ul> <heading>Example 9</heading> <p num="p-0062">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0035-0001" num="0156">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0036-0001" num="0157">8 g imidacloprid</li> </ul> </li> <li id="ul0035-0002" num="0158">46.8 g N-methylpyrrolidone
    <ul> <li id="ul0037-0001" num="0159">0.1 g lactic acid</li> <li id="ul0037-0002" num="0160">0.1 g butylated hydroxyanisole</li> </ul> </li> </ul> <heading>Example 10</heading> <p num="p-0063">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0038-0001" num="0162">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0038-0002" num="0163">10 g imidacloprid (1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-2-imidazolidinium) from Bayer AG</li> <li id="ul0038-0003" num="0164">39.8 g N-methylpyrrolidone
    <ul> <li id="ul0039-0001" num="0165">0.1 g citric acid</li> <li id="ul0039-0002" num="0166">0.1 g BHT (butylated hydroxytoluene)</li> <li id="ul0039-0003" num="0167">5.0 g Miglyol 812 from Sasol Germany GmbH. D-58453 Witten</li> </ul> </li> </ul> <heading>Example 11</heading> <p num="p-0064">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0040-0001" num="0169">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0040-0002" num="0170">10 g imidacloprid</li> <li id="ul0040-0003" num="0171">35.8 g N-methylpyrrolidone
    <ul> <li id="ul0041-0001" num="0172">4.0 g water</li> <li id="ul0041-0002" num="0173">0.1 g citric acid</li> <li id="ul0041-0003" num="0174">0.1 g BHT</li> <li id="ul0041-0004" num="0175">5.0 g Miglyol 840 from Sasol Germany GmbH. D-58453 Witten</li> </ul> </li> </ul> <heading>Example 12</heading> <p num="p-0065">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0042-0001" num="0177">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0042-0002" num="0178">10 g Ti 435, Chlothianidine from Takeda AG</li> <li id="ul0042-0003" num="0179">39.8 g N-methylpyrrolidone
    <ul> <li id="ul0043-0001" num="0180">0.1 g citric acid</li> <li id="ul0043-0002" num="0181">0.1 g BHT</li> <li id="ul0043-0003" num="0182">5.0 g tetrahydrofurfuryl alcohol</li> </ul> </li> </ul> <heading>Example 13</heading> <p num="p-0066">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0044-0001" num="0184">45 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0044-0002" num="0185">10 g Diacloden (thiamethoxam) from Novartis AG</li> <li id="ul0044-0003" num="0186">39.8 g N-methylpyrrolidone
    <ul> <li id="ul0045-0001" num="0187">0.1 g citric acid</li> <li id="ul0045-0002" num="0188">0.1 g BHT</li> <li id="ul0045-0003" num="0189">5.0 g tetrahydrofurfuryl ethoxylate</li> </ul> </li> </ul> <heading>Example 14</heading> <p num="p-0067">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0046-0001" num="0191">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0047-0001" num="0192">7.5 g imidacloprid</li> </ul> </li> <li id="ul0046-0002" num="0193">40.0 g N-methylpyrrolidone</li> <li id="ul0046-0003" num="0194">0.1 g citric acid
    <ul> <li id="ul0048-0001" num="0195">0.1 g BHT</li> <li id="ul0048-0002" num="0196">3.3 g Miglyol 812</li> </ul> </li> </ul> <heading>Example 15</heading> <p num="p-0068">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0049-0001" num="0198">47.5 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0049-0002" num="0199">10.0 g imidacloprid</li> <li id="ul0049-0003" num="0200">33.8 g N-methylpyrrolidone
    <ul> <li id="ul0050-0001" num="0201">4.0 g water</li> <li id="ul0050-0002" num="0202">0.1 g citric acid</li> <li id="ul0050-0003" num="0203">0.1 g BHT (butylated hydroxytoluene)</li> <li id="ul0050-0004" num="0204">5.0 g Miglyol 812</li> </ul> </li> </ul> <heading>Example 16</heading> <p num="p-0069">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0051-0001" num="0206">47.5 g permethrin comprising 40% cis and 60% trans isomers</li> <li id="ul0051-0002" num="0207">10 g imidacloprid</li> <li id="ul0051-0003" num="0208">34.3 g N-methylpyrrolidone
    <ul> <li id="ul0052-0001" num="0209">0.1 g citric acid</li> <li id="ul0052-0002" num="0210">0.1 g BHT</li> <li id="ul0052-0003" num="0211">4.0 g tetrahydrofurfuryl alcohol</li> <li id="ul0052-0004" num="0212">4.0 g Miglyol 812</li> </ul> </li> </ul> <heading>Example 17</heading> <p num="p-0070">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0053-0001" num="0214">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0054-0001" num="0215">8 g imidacloprid</li> </ul> </li> <li id="ul0053-0002" num="0216">40.8 g N-methylpyrrolidone
    <ul> <li id="ul0055-0001" num="0217">0.1 g lactic acid</li> <li id="ul0055-0002" num="0218">0.1 g BHT</li> <li id="ul0055-0003" num="0219">6.0 g tetrahydrofurfuryl alcohol</li> </ul> </li> </ul> <heading>Example 18</heading> <p num="p-0071">A homogeneous spot-on solution comprising
</p> <ul> <li id="ul0056-0001" num="0221">45 g permethrin comprising 40% cis and 60% trans isomers
    <ul> <li id="ul0057-0001" num="0222">8 g imidacloprid</li> </ul> </li> <li id="ul0056-0002" num="0223">42.8 g N-methylpyrrolidone
    <ul> <li id="ul0058-0001" num="0224">0.1 g lactic acid</li> <li id="ul0058-0002" num="0225">0.1 g butylated hydroxyanisole</li> <li id="ul0058-0003" num="0226">4.0 g diethylene glycol monoethyl ether
<br>
A. Activity Against Fleas on Dogs
</li> </ul> </li> </ul> <p num="p-0072">
      <i>Ctenocephalides felis </i>
    </p>
    <p num="p-0073">On days −4 and −1, dogs are infested with about 100 adult unfed <i>Ctenocephalides felis </i>per dog. The fleas are placed on the neck of the animal.</p>
    <p num="p-0074">On day 0, the success of the infestation on the dog is examined by checking the awake animal for fleas. The number of live fleas is noted.</p>
    <p num="p-0075">After the fleas have been counted, the animals are treated. The dogs of the control group are not treated. The medicaments to be examined according to Examples 1 to 18 are administered to the animals dermally as a spot-on in an application rate of 0.1 ml/kg of body weight. The application is carried out once on day 0. Only animals that are clinically healthy are used.</p>
    <p num="p-0076">On day 1, all dogs are examined for live fleas. The results are noted with the crude data.</p>
    <p num="p-0077">On days 7, 14, 21 and 28, all dogs are reinfested with about 100 adult unfed <i>Ctenocephalides felis </i>per dog. In each case one day after the reinfestation, all dogs are checked for live fleas. The results are noted with the crude data.</p>
    <p num="p-0078">A formulation is considered to be highly active if, on day 1 and in each case on the second day after reinfestation, an efficacy of &gt;95% is found, and this action persists for at least 3-4 weeks.</p>
    <p num="p-0079">The efficacy is calculated using a modified formula according to Abbott:</p>
    <p num="p-0080">
      <maths id="MATH-US-00001" num="00001"> <math overflow="scroll"> <mrow> <mrow> <mi>Efficacy</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>%</mi> </mrow> <mo>=</mo> <mrow> <mfrac> <mrow> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>fleas</mi> </mrow> <mo>-</mo> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>fleas</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>TG</mi> </mrow> </mrow> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>fleas</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>CG</mi> </mrow> </mfrac> <mo>×</mo> <mn>100</mn> </mrow> </mrow> </math> </maths> </p> <ul> <li id="ul0059-0001" num="0236">CG: Control group</li>
        <li id="ul0059-0002" num="0237">TG: Treatment group</li>
      </ul> <p num="p-0081">The medicaments of Formulation Examples 1 to 18, applied as a spot-on at a dosage of 0.1 ml/kg, were found to be highly effective against <i>Ctenocephalides felis. </i> </p>
    <p num="h-0020">B. Efficacy Against Ticks (<i>Rhipicefalus sanguineus</i>) on Dogs</p>
    <p num="p-0082">In each case on days −4 and −1, dogs are sedated using 2% Rompun® (Bayer AG, active compound: xylazine hydrochloride) (0.1 ml/kg of body weight). Once all dogs have been sedated (after about 10-15 minutes), they are transferred to transport boxes, and 50 <i>Rhipicefalus sanguineus </i>(25 ♀. 25 ♂) per dog are applied to the neck of the animal. After about 1½ hours, the animals are retransferred from the transport box into the cage.</p>
    <p num="p-0083">On day 0, the success of the infestation on the dog is examined by checking the awake animal for ticks. An intensive search is carried out in the region of the head and the ears, including the folds of the ears, in the region of the neck, on the lower abdomen, on the lower breast, on the flank and in between the toes and the limbs. The number of sucking live ticks is noted. Dead ticks are removed.</p>
    <p num="p-0084">After the ticks have been counted, the animals are treated. The dogs of the control group are not treated. The medicaments to be examined are administered to the animals dermally, as a spot-on. Application is carried out once on day 0. Only animals which are clinically healthy are used.</p>
    <p num="p-0085">On day 1 and day 2, all dogs are checked for living and dead sucking ticks. The results are noted with the crude data. On day 2, all living and dead ticks are removed from the dog.</p>
    <p num="p-0086">On days 7, 14, 21 and 28, all dogs are reinfested with in each case 50 <i>Rhipicefalus sanguineus </i>(25 ♀, 25 ♂) per dog. In each case one and two days after the reinfestation, all dogs are checked for living and dead sucking ticks. The results are noted with the crude data. On the second day after the reinfestation, all living and dead ticks are removed from the dog.</p>
    <p num="p-0087">A formulation is considered to be highly active if, on day 2 and in each case on the second day after reinfestation, an efficacy of &gt;90% is found, and this action persists for at least 3 weeks.</p>
    <p num="p-0088">For calculating the efficacy, a modified formula according to Abbott is used:</p>
    <p num="p-0089">
      <maths id="MATH-US-00002" num="00002"> <math overflow="scroll"> <mrow> <mrow> <mi>Efficacy</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>%</mi> </mrow> <mo>=</mo> <mrow> <mfrac> <mrow> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.6em" height="0.6ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>ticks</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>CG</mi> </mrow> <mo>-</mo> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>ticks</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>TG</mi> </mrow> </mrow> <mrow> <mi>∅</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>number</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>of</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>ticks</mi> <mo>⁢</mo> <mstyle> <mspace width="0.8em" height="0.8ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>CG</mi> </mrow> </mfrac> <mo>×</mo> <mn>100</mn> </mrow> </mrow> </math> </maths> </p> <ul> <li id="ul0060-0001" num="0247">CG: Control group</li>
        <li id="ul0060-0002" num="0248">TG: Treatment group.</li>
      </ul> <p num="p-0090">The medicaments according to Formulation Examples 1 to 18, applied as a spot-on at a dosage of 0.1 ml/kg, were found to be highly effective against <i>Rhipicefalus sanguineus. </i> </p>
    <p num="h-0021">C. Activity Against Fleas and Ticks Over a Period of 6 Weeks</p>
    <p num="p-0091">The activity of the compositions according to the invention against fleas and ticks was tested over a period of 6 weeks. The test was carried out analogously to the description given under items A and B.</p>
    <p num="p-0092">
      <tables id="TABLE-US-00001" num="00001"> <table frame="none" colsep="0" rowsep="0" pgwide="1" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="1"> <colspec colname="1" colwidth="385pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td namest="1" nameend="1" rowsep="1" class="description-td" colspan="1">TABLE 1</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td" colspan="1"> </td>
              </tr> <tr class="description-tr"> <td class="description-td">Activity of the composition according to Example 10 against fleas and ticks</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td" colspan="1"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="6"> <colspec colname="1" colwidth="28pt" align="center"> </colspec> <colspec colname="2" colwidth="77pt" align="left"> </colspec> <colspec colname="3" colwidth="70pt" align="center"> </colspec> <colspec colname="4" colwidth="70pt" align="center"> </colspec> <colspec colname="5" colwidth="70pt" align="center"> </colspec> <colspec colname="6" colwidth="70pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Activity against fleas</td>
                <td class="description-td">Activity against fleas</td>
                <td class="description-td">Activity against fleas</td>
                <td class="description-td">Activity against fleas</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">(geo. mean)/</td>
                <td class="description-td">(geo. mean)/</td>
                <td class="description-td">(geo. mean)/</td>
                <td class="description-td">(geo. mean)/</td>
              </tr> <tr class="description-tr"> <td class="description-td">Number</td>
                <td class="description-td">Design of the</td>
                <td class="description-td">Activity against ticks</td>
                <td class="description-td">Activity against ticks</td>
                <td class="description-td">Activity against ticks</td>
                <td class="description-td">Activity against ticks</td>
              </tr> <tr class="description-tr"> <td class="description-td">of the</td>
                <td class="description-td">study/application volume</td>
                <td class="description-td">(geo. mean) 1-2 days</td>
                <td class="description-td">(geo. mean) 1 week</td>
                <td class="description-td">(geo. mean) 2 weeks</td>
                <td class="description-td">(geo. mean) 3 weeks</td>
              </tr> <tr class="description-tr"> <td class="description-td">study</td>
                <td class="description-td">0.1 ml/kg</td>
                <td class="description-td">after treatment</td>
                <td class="description-td">after treatment</td>
                <td class="description-td">after treatment</td>
                <td class="description-td">after treatment</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="6" align="center" rowsep="1" class="description-td" colspan="6"> </td>
              </tr> <tr class="description-tr"> <td class="description-td">1</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">100%/87.2%</td>
                <td class="description-td">100%/89.9%</td>
                <td class="description-td">100%/89.9%</td>
                <td class="description-td">95.3%/97.6%</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>Rhipicephalus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>sanguineus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td">2</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">100%/38.9%</td>
                <td class="description-td">100%/100% </td>
                <td class="description-td">100%/100% </td>
                <td class="description-td">99.7%/100% </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>Amblyomma</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>americanum</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td">3</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">100%/67.0%</td>
                <td class="description-td">100%/95.9%</td>
                <td class="description-td">99.8%/96.8%</td>
                <td class="description-td">98.9%/94.1%</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>Rhipicephalus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">
                  <i>sanguineus</i>
                </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="6" align="center" rowsep="1" class="description-td" colspan="6"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="6"> <colspec colname="offset" colwidth="70pt" align="left"> </colspec> <colspec colname="1" colwidth="28pt" align="center"> </colspec> <colspec colname="2" colwidth="77pt" align="left"> </colspec> <colspec colname="3" colwidth="70pt" align="center"> </colspec> <colspec colname="4" colwidth="70pt" align="center"> </colspec> <colspec colname="5" colwidth="70pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">Activity against fleas</td>
                <td class="description-td">Activity against fleas</td>
                <td class="description-td">Activity against fleas</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">(geo. mean)/</td>
                <td class="description-td">(geo. mean)/</td>
                <td class="description-td">(geo. mean)/</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Number</td>
                <td class="description-td">Design of the</td>
                <td class="description-td">Activity against ticks</td>
                <td class="description-td">Activity against ticks</td>
                <td class="description-td">Activity against ticks</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">of the</td>
                <td class="description-td">study/application volume</td>
                <td class="description-td">(geo. mean) 4 weeks</td>
                <td class="description-td">(geo. mean) 5 weeks</td>
                <td class="description-td">(geo. mean) 6 weeks</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">study</td>
                <td class="description-td">0.1 ml/kg</td>
                <td class="description-td">after treatment</td>
                <td class="description-td">after treatment</td>
                <td class="description-td">after treatment</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="offset" nameend="5" align="center" rowsep="1" class="description-td" colspan="6"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">1</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">95.9%/91.4%</td>
                <td class="description-td">90.6%/85.5%</td>
                <td class="description-td">92.3%/83.6%</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>Rhipicephalus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>sanguineus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">2</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">99.0%/50.0%</td>
                <td class="description-td">96.3%/92.8%</td>
                <td class="description-td">99.0%/50.0%</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>Amblyomma</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>americanum</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">3</td>
                <td class="description-td"> <i>Ctenocephalides felis</i>/</td>
                <td class="description-td">94.5%/85.0%</td>
                <td class="description-td">68.1%/80.0%</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>Rhipicephalus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td"> </td>
                <td class="description-td">
                  <i>sanguineus</i>
                </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="offset" nameend="5" align="center" rowsep="1" class="description-td" colspan="6"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4590272">US4590272</a></td><td class="patent-data-table-td patent-date-value">Oct 3, 1984</td><td class="patent-data-table-td patent-date-value">May 20, 1986</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Pesticidal 1-(substituted benzyl)-2-nitromethylene-tetrahydropyrimidines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4647570">US4647570</a></td><td class="patent-data-table-td patent-date-value">Feb 8, 1985</td><td class="patent-data-table-td patent-date-value">Mar 3, 1987</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Pesticidal novel nitromethylene derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4742060">US4742060</a></td><td class="patent-data-table-td patent-date-value">Jan 21, 1986</td><td class="patent-data-table-td patent-date-value">May 3, 1988</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K. K.</td><td class="patent-data-table-td ">Heterocyclic compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4772620">US4772620</a></td><td class="patent-data-table-td patent-date-value">Aug 22, 1986</td><td class="patent-data-table-td patent-date-value">Sep 20, 1988</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Nitromethylene derivatives and their use as insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4774247">US4774247</a></td><td class="patent-data-table-td patent-date-value">Mar 23, 1987</td><td class="patent-data-table-td patent-date-value">Sep 27, 1988</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Nitromethylene derivative insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4806553">US4806553</a></td><td class="patent-data-table-td patent-date-value">Jun 18, 1987</td><td class="patent-data-table-td patent-date-value">Feb 21, 1989</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Pyridyl alkylenediamine compounds insecticidal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4849432">US4849432</a></td><td class="patent-data-table-td patent-date-value">Feb 24, 1987</td><td class="patent-data-table-td patent-date-value">Jul 18, 1989</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Heterocyclic compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4882344">US4882344</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 1988</td><td class="patent-data-table-td patent-date-value">Nov 21, 1989</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4914113">US4914113</a></td><td class="patent-data-table-td patent-date-value">Nov 1, 1988</td><td class="patent-data-table-td patent-date-value">Apr 3, 1990</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Insecticidal imidazolines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4918086">US4918086</a></td><td class="patent-data-table-td patent-date-value">Jul 27, 1988</td><td class="patent-data-table-td patent-date-value">Apr 17, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">Pesticides, insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4918088">US4918088</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 1988</td><td class="patent-data-table-td patent-date-value">Apr 17, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">Acarina</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4948798">US4948798</a></td><td class="patent-data-table-td patent-date-value">Aug 21, 1989</td><td class="patent-data-table-td patent-date-value">Aug 14, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">Substituted cyanoiminoimidazolidines and -tetrahydropyrimidines useful as pesticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4963572">US4963572</a></td><td class="patent-data-table-td patent-date-value">Aug 8, 1988</td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">Especially rice crops</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4963574">US4963574</a></td><td class="patent-data-table-td patent-date-value">Feb 16, 1988</td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td ">Ciba-Geigy Corporation</td><td class="patent-data-table-td ">N-cyanoisothiourea compounds useful in pest control</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4988696">US4988696</a></td><td class="patent-data-table-td patent-date-value">Aug 24, 1989</td><td class="patent-data-table-td patent-date-value">Jan 29, 1991</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Dermal treatment of worm diseases in cats with praziquantel</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5034404">US5034404</a></td><td class="patent-data-table-td patent-date-value">Dec 27, 1989</td><td class="patent-data-table-td patent-date-value">Jul 23, 1991</td><td class="patent-data-table-td ">Takeda Chemical Industries, Ltd.</td><td class="patent-data-table-td ">Nitroguanidines as insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5034524">US5034524</a></td><td class="patent-data-table-td patent-date-value">Nov 7, 1990</td><td class="patent-data-table-td patent-date-value">Jul 23, 1991</td><td class="patent-data-table-td ">Nihon Tokushu Noyaku Seizo K.K.</td><td class="patent-data-table-td ">Insecticidal heterocyclic compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5039686">US5039686</a></td><td class="patent-data-table-td patent-date-value">Oct 31, 1989</td><td class="patent-data-table-td patent-date-value">Aug 13, 1991</td><td class="patent-data-table-td ">Shell Internationale Research Maatschappij B.V.</td><td class="patent-data-table-td ">N-pyridyl nitromethylene heterocyclic compounds and their use as pesticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5074252">US5074252</a></td><td class="patent-data-table-td patent-date-value">Jul 16, 1990</td><td class="patent-data-table-td patent-date-value">Dec 24, 1991</td><td class="patent-data-table-td ">Morgan Jr Charles</td><td class="patent-data-table-td ">Rechargeable insecticide dispenser providing controlled release of an insecticide composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5236954">US5236954</a></td><td class="patent-data-table-td patent-date-value">May 30, 1991</td><td class="patent-data-table-td patent-date-value">Aug 17, 1993</td><td class="patent-data-table-td ">Pitman-Moore, Inc.</td><td class="patent-data-table-td ">Pyrethroid in ether carrier</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5253182">US5253182</a></td><td class="patent-data-table-td patent-date-value">Feb 11, 1991</td><td class="patent-data-table-td patent-date-value">Oct 12, 1993</td><td class="patent-data-table-td ">Hitachi, Ltd.</td><td class="patent-data-table-td ">Method of and apparatus for converting design pattern data to exposure data</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5435992">US5435992</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 1993</td><td class="patent-data-table-td patent-date-value">Jul 25, 1995</td><td class="patent-data-table-td ">Roussel Uclaf</td><td class="patent-data-table-td ">Insecticides or parasiticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6001858">US6001858</a></td><td class="patent-data-table-td patent-date-value">Nov 27, 1995</td><td class="patent-data-table-td patent-date-value">Dec 14, 1999</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Parasiticide formulations suitable for dermal application</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6033731">US6033731</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 1998</td><td class="patent-data-table-td patent-date-value">Mar 7, 2000</td><td class="patent-data-table-td ">Nova Chemicals, Inc.</td><td class="patent-data-table-td ">Impregnating polymer beads with insecticide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6080796">US6080796</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 1998</td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td ">Nova Chemicals Inc.</td><td class="patent-data-table-td ">Emulsion polymerization of styrenic monomer mixture in which insecticide is dissolved to form polymeric beads, impregnating beads with a blowing agent to form foamed construction material resistant to termites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6232328">US6232328</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 1997</td><td class="patent-data-table-td patent-date-value">May 15, 2001</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Non-systemic control of parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7384938">US7384938</a></td><td class="patent-data-table-td patent-date-value">Jan 17, 2003</td><td class="patent-data-table-td patent-date-value">Jun 10, 2008</td><td class="patent-data-table-td ">Bayer Aktiengesellschaft</td><td class="patent-data-table-td ">Aqueous formulations of parasiticides for skin applications</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20020103233">US20020103233</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 30, 2000</td><td class="patent-data-table-td patent-date-value">Aug 1, 2002</td><td class="patent-data-table-td ">Arther Robert G.</td><td class="patent-data-table-td ">Compositions for enhanced acaricidal activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030055089">US20030055089</a></td><td class="patent-data-table-td patent-date-value">Dec 11, 1997</td><td class="patent-data-table-td patent-date-value">Mar 20, 2003</td><td class="patent-data-table-td ">Kirkor Sirinyan</td><td class="patent-data-table-td ">Endoparasiticidal and ectoparasiticidal agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DAU%26NR%3D633883B2%26KC%3DB2%26FT%3DD&amp;usg=AFQjCNHXRaXMvZDiQefvUwnoi4HGuCLxeg">AU633883B2</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN1176052A?cl=en">CN1176052A</a></td><td class="patent-data-table-td patent-date-value">Jul 23, 1997</td><td class="patent-data-table-td patent-date-value">Mar 18, 1998</td><td class="patent-data-table-td ">张天良</td><td class="patent-data-table-td ">Insecticide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN1234181A?cl=en">CN1234181A</a></td><td class="patent-data-table-td patent-date-value">Jan 8, 1999</td><td class="patent-data-table-td patent-date-value">Nov 10, 1999</td><td class="patent-data-table-td ">吕玉成</td><td class="patent-data-table-td ">Efficient cypermethrin-Imidan emulsion</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN1236547A?cl=en">CN1236547A</a></td><td class="patent-data-table-td patent-date-value">May 21, 1998</td><td class="patent-data-table-td patent-date-value">Dec 1, 1999</td><td class="patent-data-table-td ">张天良</td><td class="patent-data-table-td ">Insecticide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE3639877A1?cl=en">DE3639877A1</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 1986</td><td class="patent-data-table-td patent-date-value">May 26, 1988</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Hetarylalkyl substituierte 5- und 6-ringheterocyclen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE3712307A1?cl=en">DE3712307A1</a></td><td class="patent-data-table-td patent-date-value">Apr 10, 1987</td><td class="patent-data-table-td patent-date-value">Oct 20, 1988</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">3-substituierte 1-(2-chlor-thiazol-5-yl-methyl)-2- nitroimino-1,3-diazacycloalkane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0135956A2?cl=en">EP0135956A2</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 1984</td><td class="patent-data-table-td patent-date-value">Apr 3, 1985</td><td class="patent-data-table-td ">Shell Internationale Research Maatschappij B.V.</td><td class="patent-data-table-td ">Novel pesticidal heterocyclic compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0189972A1?cl=en">EP0189972A1</a></td><td class="patent-data-table-td patent-date-value">Jan 8, 1986</td><td class="patent-data-table-td patent-date-value">Aug 6, 1986</td><td class="patent-data-table-td ">Fine Organics Limited</td><td class="patent-data-table-td ">Preparation of thiazine derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0302389A2?cl=en">EP0302389A2</a></td><td class="patent-data-table-td patent-date-value">Jul 28, 1988</td><td class="patent-data-table-td patent-date-value">Feb 8, 1989</td><td class="patent-data-table-td ">Takeda Chemical Industries, Ltd.</td><td class="patent-data-table-td ">Alpha-unsaturated amines, their production and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0364844A1?cl=en">EP0364844A1</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 1989</td><td class="patent-data-table-td patent-date-value">Apr 25, 1990</td><td class="patent-data-table-td ">Nihon Bayer Agrochem K.K.</td><td class="patent-data-table-td ">Insecticidally active cyano compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0368565A1?cl=en">EP0368565A1</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 1989</td><td class="patent-data-table-td patent-date-value">May 16, 1990</td><td class="patent-data-table-td ">Kabushiki Kaisha Toshiba</td><td class="patent-data-table-td ">Low thermal expansion cast iron, moulds constructed thereof and their use in moulding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0375907A1?cl=en">EP0375907A1</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 1989</td><td class="patent-data-table-td patent-date-value">Jul 4, 1990</td><td class="patent-data-table-td ">Nihon Bayer Agrochem K.K.</td><td class="patent-data-table-td ">Insecticidally active nitro compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0383091A1?cl=en">EP0383091A1</a></td><td class="patent-data-table-td patent-date-value">Jan 31, 1990</td><td class="patent-data-table-td patent-date-value">Aug 22, 1990</td><td class="patent-data-table-td ">Nihon Bayer Agrochem K.K.</td><td class="patent-data-table-td ">Insecticidally active nitro compounds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0425978A2?cl=en">EP0425978A2</a></td><td class="patent-data-table-td patent-date-value">Oct 23, 1990</td><td class="patent-data-table-td patent-date-value">May 8, 1991</td><td class="patent-data-table-td ">Agro-Kanesho Co., Ltd.</td><td class="patent-data-table-td ">Nitroguanidine compounds and insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0428941A1?cl=en">EP0428941A1</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 1990</td><td class="patent-data-table-td patent-date-value">May 29, 1991</td><td class="patent-data-table-td ">Agro-Kanesho Co., Ltd.</td><td class="patent-data-table-td ">Hexahydrotriazine compounds and insecticides</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0455000A1?cl=en">EP0455000A1</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 1991</td><td class="patent-data-table-td patent-date-value">Nov 6, 1991</td><td class="patent-data-table-td ">MITSUI TOATSU CHEMICALS, Inc.</td><td class="patent-data-table-td ">Dialkoxymethylimidazolidine derivatives, preparation thereof, insecticides containing same as an effective ingredient and intermediates therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0461962A1?cl=en">EP0461962A1</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 1991</td><td class="patent-data-table-td patent-date-value">Dec 18, 1991</td><td class="patent-data-table-td ">Sumitomo Chemical Company, Limited</td><td class="patent-data-table-td ">Acaricidal composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0464830A1?cl=en">EP0464830A1</a></td><td class="patent-data-table-td patent-date-value">Jul 4, 1991</td><td class="patent-data-table-td patent-date-value">Jan 8, 1992</td><td class="patent-data-table-td ">Agro-Kanesho Co., Ltd.</td><td class="patent-data-table-td ">Organophosphorus compounds, method for preparing same and insecticides, acaricides and nematocides containing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0471372A1?cl=en">EP0471372A1</a></td><td class="patent-data-table-td patent-date-value">Aug 15, 1991</td><td class="patent-data-table-td patent-date-value">Feb 19, 1992</td><td class="patent-data-table-td ">Takeda Chemical Industries, Ltd.</td><td class="patent-data-table-td ">Novel substituted guanidine derivatives, their preparation and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0682869A1?cl=en">EP0682869A1</a></td><td class="patent-data-table-td patent-date-value">May 8, 1995</td><td class="patent-data-table-td patent-date-value">Nov 22, 1995</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Non-systemic control of parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0976328A2?cl=en">EP0976328A2</a></td><td class="patent-data-table-td patent-date-value">Jul 19, 1999</td><td class="patent-data-table-td patent-date-value">Feb 2, 2000</td><td class="patent-data-table-td ">Sumitomo Chemical Company, Limited</td><td class="patent-data-table-td ">Ectoparasite controlling agent for animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0981955A2?cl=en">EP0981955A2</a></td><td class="patent-data-table-td patent-date-value">Aug 10, 1999</td><td class="patent-data-table-td patent-date-value">Mar 1, 2000</td><td class="patent-data-table-td ">Nova Chemicals Inc.</td><td class="patent-data-table-td ">Impregnating polymer beads with insecticide</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DFR%26NR%3D2784011A1%26KC%3DA1%26FT%3DD&amp;usg=AFQjCNE7rQu_R3FPaMkSgWU8EUGmgIlLGA">FR2784011A1</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH0789803A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGPNIPOuwRWPZk4L8c7rCvwCNO6Dg">JPH0789803A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH1179917A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHThDYPvA7Fy0pY3k-YNw2L1U-SvQ">JPH1179917A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH02207083A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNEDbbH4WwzJ1tj-8kDJFzSYTyJ7Rw">JPH02207083A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH03220176A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGDKhW8Sc7I-d6yM0kLHqzMs-7Bkg">JPH03220176A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH03255072A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNExrMVh4B13Mc11JHLpN3qN_D3QuA">JPH03255072A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH03279359A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNH4go2amOHcbhuESmsUtdgrmBGZfA">JPH03279359A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH07247203A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGewzLxuVUmpeCtgmydyJtn8oSxKg">JPH07247203A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DS63287764A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHPWhoB3VtU0fVz3VM3ZIWL9llqBA">JPS63287764A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DS63307857A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFH5pMY5rcDPiyozBzcl758IWYeNQ">JPS63307857A</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DRU%26NR%3D2127517C1%26KC%3DC1%26FT%3DD&amp;usg=AFQjCNGXTRrX9bAsQZ9-HiXZsSlJHfp0XQ">RU2127517C1</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=r8l2BgABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DRU%26NR%3D2130259C1%26KC%3DC1%26FT%3DD&amp;usg=AFQjCNFfaI8tsR78z9fsSiasf0M6bjujtQ">RU2130259C1</a></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1991017659A1?cl=en">WO1991017659A1</a></td><td class="patent-data-table-td patent-date-value">May 10, 1991</td><td class="patent-data-table-td patent-date-value">Nov 28, 1991</td><td class="patent-data-table-td ">Du Pont</td><td class="patent-data-table-td ">Arthropodicidal nitroethylenes and nitroguanidines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1995017090A1?cl=en">WO1995017090A1</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 1994</td><td class="patent-data-table-td patent-date-value">Jun 29, 1995</td><td class="patent-data-table-td ">Sun Glitz Corp</td><td class="patent-data-table-td ">Water resistant pesticide composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1996017520A1?cl=en">WO1996017520A1</a></td><td class="patent-data-table-td patent-date-value">Nov 27, 1995</td><td class="patent-data-table-td patent-date-value">Jun 13, 1996</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Parasiticidal formulations that can be applied dermally</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000054591A2?cl=en">WO2000054591A2</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2000</td><td class="patent-data-table-td patent-date-value">Sep 21, 2000</td><td class="patent-data-table-td ">American Cyanamid Co</td><td class="patent-data-table-td ">Synergistic insecticidal compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002043494A2?cl=en">WO2002043494A2</a></td><td class="patent-data-table-td patent-date-value">Nov 26, 2001</td><td class="patent-data-table-td patent-date-value">Jun 6, 2002</td><td class="patent-data-table-td ">Bayer Ag</td><td class="patent-data-table-td ">Compositions for enhanced acaricidal activity</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Calumpang, et al., Applicator Exposure to Imidacloprid while Spraying Mangoes, Bull. Environ. Contam. Toxicol., Nov. 1996, vol. 57, pp. 697-704.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Toda, et al., Toxic Effect of Pesticides on the Larvae of Chrysperla camea, Proc. Assoc. PI. Prot. Kyushu, 1997, vol. 43, pp. 101-105.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wamhoff, et al., Photodegradation of Imidacloprid, Journal of Agricultural and Food Chemistry, Apr. 1999, vol. 47, No. 4, pp. 1730-1734.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Zheng et al., Kinetics and Mechanism of the hydrolysis of Imidacloprid, Pesticide Science, Apr. 1999, vol. 55, No. 4, pp. 482-485.</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8728507">US8728507</a></td><td class="patent-data-table-td patent-date-value">Oct 31, 2007</td><td class="patent-data-table-td patent-date-value">May 20, 2014</td><td class="patent-data-table-td ">Bayer Intellectual Property Gmbh</td><td class="patent-data-table-td ">Non-systemic control of parasites</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20080039519">US20080039519</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 27, 2005</td><td class="patent-data-table-td patent-date-value">Feb 14, 2008</td><td class="patent-data-table-td ">Bayer Healthcare Ag</td><td class="patent-data-table-td ">Anti-Demodicosis Agent</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S341000">514/341</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S531000">514/531</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S351000">514/351</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S405000">424/405</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031530000">A61K31/53</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031443900">A61K31/4439</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009080000">A61K9/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0033140000">A61P33/14</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031426000">A61K31/426</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031535000">A61K31/535</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0053000000">A01N53/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01P0007000000">A01P7/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0025020000">A01N25/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0277200000">C07D277/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0277320000">C07D277/32</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0417060000">C07D417/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047220000">A61K47/22</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047020000">A61K47/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0043400000">A01N43/40</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031440000">A61K31/44</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0213610000">C07D213/61</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A01N0053080000">A01N53/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047120000">A61K47/12</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047100000">A61K47/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031215000">A61K31/215</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C07D0401060000">C07D401/06</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=r8l2BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A01N53/00">A01N53/00</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A01N53/00</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Nov 20, 2013</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 1, 2013</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120401</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER ANIMAL HEALTH GMBH;REEL/FRAME:030127/0549</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER INTELLECTUAL PROPERTY GMBH, GERMANY</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 29, 2013</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIMS 1-4 IS CONFIRMED.NEW CLAIMS 5-6 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 28, 2011</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20110506</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 5, 2009</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER ANIMAL HEALTH GMBH, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER AKTIENGESELLSCHAFT;REEL/FRAME:022213/0488</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20081204</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER AKTIENGESELLSCHAFT;REEL/FRAME:22213/488</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER ANIMAL HEALTH GMBH,GERMANY</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 29, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER AKTIENGESELLSCHAFT, GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIRINYAN, KIRKOR;DORN, HUBERT;GILGES, MARTIN;AND OTHERS;REEL/FRAME:015274/0892</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20031103</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BAYER AKTIENGESELLSCHAFT,GERMANY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIRINYAN, KIRKOR;DORN, HUBERT;GILGES, MARTIN AND OTHERS;REEL/FRAME:15274/892</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U2_0zgKQV-rH6ntOV8YIGRy2wcZ5A\u0026id=r8l2BgABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2TGrUPTdV0EDwF1L-B1NDxFZMFKw\u0026id=r8l2BgABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1Ah-HWcKztQMqci90Cu9R_FAtWvQ","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Dermally_applicable_liquid_formulations.pdf?id=r8l2BgABERAJ\u0026output=pdf\u0026sig=ACfU3U3vKaNxPZ5yEPeL0_D1JgfsGx9-6A"},"sample_url":"http://www.google.com/patents/reader?id=r8l2BgABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>